Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

Padmanee Sharma, Margaret K. Callahan, Petri Bono, Joseph Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi N. Pillai, Patrick A. Ott, Filippo de Braud, Michael Morse, Dung T. Le, Dirk Jaeger, Emily Chan, Chris Harbison, Chen Sheng Lin, Marina Tschaika, Alex Azrilevich, Jonathan E. Rosenberg

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences